DAA1534 |
mitochondrial ribosomal protein S12 |
Molecular |
liver |
Mouse |
Mrps12 |
5.0% Increase Gene Expression Level |
|
DAA519 |
mitochondrial ribosomal protein S15 |
Molecular |
skeletal muscle |
Human |
MRPS15 |
3.0% Decrease Gene Expression Level |
|
DAA465 |
mitochondrial ribosomal protein S22 |
Molecular |
skeletal muscle |
Human |
MRPS22 |
1.0% Decrease Gene Expression Level |
|
DAA1789 |
mitochondrial ribosomal protein S23 |
Molecular |
muscle |
Mouse |
Mrps23 |
2.0% Decrease Gene Expression Level |
|
DAA528 |
mitochondrial ribosomal protein S24 |
Molecular |
skeletal muscle |
Human |
MRPS24 |
2.0% Decrease Gene Expression Level |
|
DAA511 |
mitochondrial ribosomal protein S30 |
Molecular |
skeletal muscle |
Human |
MRPS30 |
2.0% Decrease Gene Expression Level |
|
DAA361 |
mitochondrial ribosomal protein S7 |
Molecular |
skeletal muscle |
Human |
MRPS7 |
2.0% Decrease Gene Expression Level |
|
DAA131 |
mitogen-activated protein kinase 1 |
Molecular |
brain |
Human |
MAPK1 |
17.0% Decrease Gene Expression Level |
|
DAA579 |
mitogen-activated protein kinase 6 |
Molecular |
skeletal muscle |
Human |
MAPK6 |
4.0% Decrease Gene Expression Level |
|
DAA132 |
mitogen-activated protein kinase 9 |
Molecular |
brain |
Human |
MAPK9 |
15.0% Decrease Gene Expression Level |
|
DAA130 |
mitogen-activated protein kinase kinase 1 |
Molecular |
brain |
Human |
MAP2K1 |
7.0% Decrease Gene Expression Level |
|
DAA1784 |
mitogen-activated protein kinase kinase 2 |
Molecular |
muscle |
Mouse |
Map2k2 |
3.0% Increase Gene Expression Level |
|
DAA1785 |
mitogen-activated protein kinase kinase 6 |
Molecular |
muscle |
Mouse |
Map2k6 |
8.0% Decrease Gene Expression Level |
|
DAA456 |
mitogen-activated protein kinase kinase kinase 15 |
Molecular |
skeletal muscle |
Human |
MAP3K15 |
8.0% Decrease Gene Expression Level |
|
DAA1357 |
mitogen-activated protein kinase kinase kinase 9 |
Molecular |
hematological system |
Mouse |
Map3k9 |
16.0% Increase Gene Expression Level |
|
DAA1925 |
mitogen-activated protein kinase kinase kinase kinase 2 |
Molecular |
Anatomical System |
Mouse |
Map4k2 |
19.0% Decrease Gene Expression Level |
|
DAA311 |
mitogen-activated protein kinase kinase kinase kinase 3 |
Molecular |
skeletal muscle |
Human |
MAP4K3 |
5.0% Increase Gene Expression Level |
|
DAA2085 |
mitogen-activated protein kinase kinase kinase kinase 4 increases with age |
Molecular |
ovary |
Human |
MAP4K4 |
69.0% Increase Gene Expression Level |
|
DAA455 |
mixed lineage kinase domain-like |
Molecular |
skeletal muscle |
Human |
MLKL |
7.0% Decrease Gene Expression Level |
|
DAA1539 |
Moloney sarcoma oncogene |
Molecular |
liver |
Mouse |
Mos |
28.0% Decrease Gene Expression Level |
|
DAA1350 |
molybdenum cofactor sulfurase |
Molecular |
hematological system |
Mouse |
Mocos |
18.0% Increase Gene Expression Level |
|
DAA140 |
monocyte to macrophage differentiation-associated |
Molecular |
brain |
Human |
MMD |
7.0% Decrease Gene Expression Level |
|
DAA854 |
More severe manifestations of gastroesophageal reflux disease |
Pathological |
oesophagus, stomach |
Human |
— |
— |
|
DAA854 |
More severe manifestations of gastroesophageal reflux disease |
Pathological |
oesophagus, stomach |
Human |
— |
— |
|
DAA1219 |
Morning concentration of oestrone (E1) declines |
Physiological |
plasma |
Human |
— |
— |
|